logo
Select company
Select metric
$ -177.01MConsolidated Income
VS
Market
7
Sector
13
Industry
17
History
-
$ 26.03Close
$ 6.43 - $ 27.76 52-Week Range
Ticker Information

Ticker

ZBIO

Company Name

ZENAS BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZENAS BIOPHARMA INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZBIO - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -177.01M
12/31/2024$ -156.99M
12/31/2023$ -37.12M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZENAS BIOPHARMA INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -37.12M.
  • Over the past 5 years, ZENAS BIOPHARMA INC's average Cons. Inc. has been $ -123.71M.
  • The median Cons. Inc. for ZENAS BIOPHARMA INC during this period was $ -156.99M
  • ZENAS BIOPHARMA INC reached its highest Cons. Inc. over the past 5 years at $ -37.12M.
  • The lowest Cons. Inc. recorded by ZENAS BIOPHARMA INC in the same timeframe $ -177.01M

ZENAS BIOPHARMA INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
ABUS : ARBUTUS BIOPHARMA CORP $ -54.25MQURE : UNIQURE NV $ -199MNUVB : NUVATION BIO INC $ -202.9MVIR : VIR BIOTECHNOLOGY INC $ -550.23MBCYC : BICYCLE THERAPEUTICS PLC $ -242.36MIMNM : IMMUNOME INC $ -212.39MRLAY : RELAY THERAPEUTICS INC $ -311.55MCAPR : CAPRICOR THERAPEUTICS INC $ -69.98MTSHA : TAYSHA GENE THERAPIES INC $ -92.72MALMS : ALUMIS INC $ -227.52M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ZBIO - Consolidated Income, Last 5 years

$ -177.01M

Minimum

Jun 30, 2025

$ -37.12M

Maximum

Dec 31, 2023

$ -123.71M

Average

$ -156.99M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.01M with a standard deviation of $ 116.51M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.01M
median$ -2.1M
std$ 116.51M